No Data
Medicines Technology Co., Ltd. (HKEX: 07666): Chen Xi has been appointed as Joint Company Secretary and Authorized Representative.
Medicines Technology-P (07666) announced that Ms. Zheng Yuting has resigned as Joint Company Secretary and the company’s authorized representative under Rule 3.05 of the Listing Rules of The Stock Exchange of Hong Kong Limited, effective June 12, 2026, and that Ms. Chen Xi has been appointed as Joint Company Secretary and authorized representative, also effective June 12, 2026. Following this change, Dr. Fu Chong will continue to serve as the other Joint Company Secretary.
Hong Kong Stock Market Movement | Jetai Technology-P (07666) Rises Up to Nearly 7% After Officially Launching AiProtein Platform and Antibody Design Agent AARON Earlier This Week
Medicines Technology-P (07666) rose as much as nearly 7%. As of the time of writing, it was up 4.36% at HK$13.40, with a trading volume of HK$21.7154 million.
Metis TechBio Updates Articles After Full Exercise of H-Share Over-Allotment
Medicines Tech-P (07666) issued 30,184,000 shares pursuant to the full exercise of the over-allotment option.
Medicines Technology Co., Ltd. (HKEX: 07666) announced that on June 10, 2026, it issued and allotted 30,184,000 shares pursuant to the full exercise of the over-allotment option.
Medicines Tech-P (07666.HK) Fully Exercises Over-Allotment Option, Stabilizing Action, and Conclusion of Stabilization Period
Gelonghui, June 5 — METiS Pharmaceuticals-P (07666.HK) announced that the over-allotment option as set out in the prospectus was fully exercised on Friday, June 5, 2026, by the overall coordinator (for itself and on behalf of the international underwriters), involving a total of 30,184,000 H shares (the "Over-Allotted Shares"), representing 15% of the total number of Offer Shares initially available for subscription under the global offering prior to any exercise of the over-allotment option. The Over-Allotted Shares will be issued by the Company at HK$10.50 per H share (being the issue price per H share under the global offering, excluding 1.0% brokerage commission
JiTai Technology-P rose after announcing a strategic alliance with Deerfield to jointly develop AI-driven protein therapeutics and in vivo immunotherapies.
Medicines Technology-P (07666) rose nearly 5%. As of the time of writing, it was up 4.47% at HK$15.44, with a trading volume of HK$8.2235 million.